Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer.
Cancer cachexia is a multifactorial syndrome characterized by progressive loss of weight and muscle atrophy. Using metabolomics, we investigated serum markers and their intra-day variation in advanced pancreatic cancer patients with cachexia.Patients were enrolled in two groups: those with or withou...
Main Authors: | Yutaka Fujiwara, Takashi Kobayashi, Naoko Chayahara, Yoshinori Imamura, Masanori Toyoda, Naomi Kiyota, Toru Mukohara, Shin Nishiumi, Takeshi Azuma, Masaru Yoshida, Hironobu Minami |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4239056?pdf=render |
Similar Items
-
Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients.
by: Yutaka Fujiwara, et al.
Published: (2014-01-01) -
Mediastinal Germ Cell Tumor Exhibiting a Discrepancy between Tumor Markers and Imaging: A Case Study
by: Kei Takenaka, et al.
Published: (2015-08-01) -
Exploratory Analysis to Predict Optimal Tumor Burden for Starting Lenvatinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
by: Chiaki Suzuki, et al.
Published: (2021-07-01) -
Left atrial extension of metastatic lung tumor via pulmonary vein: report on the first case of Ewing sarcoma
by: Hironobu Minami, et al.
Published: (2010-09-01) -
Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
by: Yasuko Hyogo, et al.
Published: (2018-11-01)